Ruggaard & Associates LLC Pfizer Inc Transaction History

Ruggaard & Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $104,414 - $119,901	-4,033 Reduced 34.47%	7,667 $213 Million
Q4 2023 Feb 15, 2024	SELL	$26.13 - $33.94 $201,906 - $262,254	-7,727 Reduced 39.77%	11,700 $337 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $22,463 - $26,257	-700 Reduced 3.48%	19,427 $644 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $46,956 - $54,327	-1,300 Reduced 6.07%	20,127 $738 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $844,009 - $1.1 Million	21,427 New	21,427 $874 Million

3,222

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ruggaard & Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Ruggaard & Associates LLC with notifications on news.